Previous studies have shown that LMO1 is involved in T-cell Acute Lymphoblastic Leukemia (T-ALL) and neuroblastoma, and its role in BC, particularly in the TCGA Cluster 5, supports its potential as a marker for aggressive cancer phenotypes. The gene discussed is LMO1; the disease is breast cancer.